Malagrinò, Matteo; Piazza, Anna; Bisceglia, Nicolò; Capra, Sara; Cantone, Cristiana; Pagotto, Uberto; Zavatta, Guido, Elevated FGF23 Despite Biochemical Control Reveals Hidden Mineral Dysregulation in Chronic Hypoparathyroidism, «JOURNAL OF THE ENDOCRINE SOCIETY», 2026, 10, pp. 1 - 8 [Scientific article]
Aguanno, Francesco; Passaseo, Alessia; Barbuto, Simona; Vetrano, Daniele; Zavatta, Guido; Marzocchi, Guido; Giannini, Sandro; Comai, Giorgia; La Manna, Gaetano; Cianciolo, Giuseppe, Bone disease in kidney transplant: don't forget about osteomalacia: a case report and literature review, «INTERNATIONAL UROLOGY AND NEPHROLOGY», 2025, x, pp. 1 - 11 [Scientific article]
Palermo, A.; Naciu, A. M.; Donovan, Y. K. T.; Tabacco, G.; Zavatta, G., Review of: Correction to: PTH Substitution Therapy for Chronic Hypoparathyroidism: PTH 1–84 and Palopegteriparatide (Current Osteoporosis Reports, (2025), 23, 1, (12), 10.1007/s11914-025-00905-6), «CURRENT OSTEOPOROSIS REPORTS», 2025, 23, pp. 23 - 25 [Review]
Bisceglia, N.; Malagrino, M.; Piazza, A.; Vandi, G.; Repaci, A.; Pagotto, U.; Zavatta, G., Dietary calcium intake in primary hyperparathyroidism and in its normocalcemic variant: a case-control study, «FRONTIERS IN ENDOCRINOLOGY», 2025, 15, Article number: 1428640 , pp. 1 - 11 [Scientific article]Open Access
Vetrano, Daniele; Aguanno, Francesco; Passaseo, Alessia; Barbuto, Simona; Tondolo, Francesco; Catalano, Veronica; Zavatta, Guido; Pagotto, Uberto; La Manna, Gaetano; Cianciolo, Giuseppe, Efficacy and safety of teriparatide in kidney transplant recipients with osteoporosis and low bone turnover: a real-world experience, «INTERNATIONAL UROLOGY AND NEPHROLOGY», 2025, Online ahead of print, pp. 1 - 11 [Scientific article]Open Access
Gambineri, A; Rosa, S; Pandurevic, S; Cecchetti, C; Rotolo, L; Dionese, P; Belardinelli, E; Solmi, B; Zavatta, G; Fanelli, F; Rucci, P; Angeli, F; Armillotta, M; Bergamaschi, L; Gallitto, E; Gargiulo, M; Macut, D; Pizzi, C; Pagotto, U, Evolution of cardiovascular risk factors and the risk for cardiovascular events in a Caucasian population with polycystic ovary syndrom, «EUROPEAN JOURNAL OF ENDOCRINOLOGY», 2025, 192, pp. 210 - 219 [Scientific article]
Rotolo, Laura; Galante, Greta; Coscia, Kimberly; Bissi, Valentina; Tucci, Lorenzo; Mezzullo, Marco; Gambineri, Alessandra; Vicennati, Valentina; Zavatta, Guido; Pagotto, Uberto; Di Dalmazi, Guido; Fanelli, Flaminia, Impact of old and current immunoassays on the 1 mg overnight dexamethasone suppression test: comparison with LC-MS/MS, «EUROPEAN JOURNAL OF ENDOCRINOLOGY», 2025, 193, pp. 188 - 196 [Scientific article]Open Access
Valentini, I.; Basile, M.; Vescini, F.; Borretta, G.; Chiodini, I.; Boniardi, M.; Carotti, M.; Castellano, E.; Cipriani, C.; Eller-Vainicher, C.; Giannini, S.; Iacobone, M.; Salcuni, A. S.; Saponaro, F.; Spiezia, S.; Versari, A.; Zavatta, G.; Mitrova, Z.; Saulle, R.; Giovanazzi, A.; Novizio, R.; Paoletta, A.; Papini, E.; Persichetti, A.; Samperi, I.; Scoppola, A.; Calo, P. G.; Cetani, F.; Cianferotti, L.; Corbetta, S.; De Rimini, M. L.; Falchetti, A.; Laureti, S.; Lombardi, C. P.; Madeo, B.; Marcocci, C.; Mazzaferro, S.; Miele, V.; Minisola, S.; Palermo, A.; Pepe, J.; Scillitani, A.; Grimaldi, F.; Cozzi, R.; Attanasio, R., Micro-costing analysis from Italian Guidelines for the management of sporadic primary hyperparathyroidism, «GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT», 2025, 12, pp. 186 - 193 [Scientific article]
Palermo, A.; Naciu, A. M.; Donovan, Y. K. T.; Tabacco, G.; Zavatta, G., Review of: PTH Substitution Therapy for Chronic Hypoparathyroidism: PTH 1–84 and Palopegteriparatide, «CURRENT OSTEOPOROSIS REPORTS», 2025, 23, pp. 1 - 10 [Review]
Tabarin, A.; Espiard, S.; Deutschbein, T.; Amar, L.; Vezzossi, D.; Di Dalmazi, G.; Reznik, Y.; Young, J.; Desailloud, R.; Goichot, B.; Drui, D.; Assie, G.; Lefebvre, H.; Mai, K.; Castinetti, F.; Laboureau, S.; Terzolo, M.; Ferriere, A.; Georget, A.; Frison, E.; Vantyghem, M. -C.; Fassnacht, M.; Gosse, P.; Bertherat, J.; Cariou, B.; Cariou, T.; Cazenave, S.; Cianferani, M.; Ernoult, A.; Fonteneau, E.; Galioot, A.; Gaudissard, J.; Gaujoux, S.; Gautier, S.; Gaye, D.; Guillot, P.; Herting, M.; Khiar, H.; Lavergne, G.; Le Mapihan, K.; Mirallie, E.; Mohres, Y.; Mosnier-Pudar, H.; Mouly, C.; Pattou, F.; Perez, P.; Pericart, S.; Piton, K.; Reibetanz, J.; Rouvray, C.; Sahnoun, M.; Saidi, M.; Sauerwald, J.; Taillandier, V.; Thoulouzan, M.; Zavatta, G.; Zopf, K., Surgery for the treatment of arterial hypertension in patients with unilateral adrenal incidentalomas and mild autonomous cortisol secretion (CHIRACIC): a multicentre, open-label, superiority randomised controlled trial, «THE LANCET DIABETES & ENDOCRINOLOGY», 2025, 13, pp. 580 - 590 [Scientific article]
Tovoli, F.; Zavatta, G.; Monaco, G.; Pallotta, D. P.; Skoracka, K.; Raiteri, A.; Pratelli, A.; Boe, M.; Krela-Kazmierczak, I.; Pagotto, U.; Granito, A., TIMING THE SCAN: OPTIMIZING SCREENING FOR OSTEOPOROSIS AND RISK OF FRACTURE IN CELIAC DISEASE, «THE AMERICAN JOURNAL OF GASTROENTEROLOGY», 2025, in press, Article number: 10.14309/ajg.0000000000003750 , pp. 1 - 10 [Scientific article]
Bisceglia, N.; Malagrino, M.; Cantone, C.; Capra, S.; Piazza, A.; Vandi, G.; Zavatta, G., Trabecular bone score as a possible new surgical recommendation in patients with asymptomatic primary hyperparathyroidism, «JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION», 2025, Volume 48, pp. 1819 - 1828 [Scientific article]
Bisceglia, Nicolò; Scarano, Emanuela; Piazza, Anna; Gambineri, Alessandra; Pagotto, Uberto; Zavatta, Guido, Treatment With Romosozumab In Progressive Pseudorheumatoid Dysplasia, «JCEM CASE REPORTS», 2025, 3, Article number: luaf203 , pp. 1 - 7 [Scientific article]Open Access
Cetani, F.; Bertoldo, F.; Bononi, M.; Tarallo, M.; Camozzi, V.; Cipriani, C.; Palermo, A.; Pasquali, D.; Zavatta, G., Review of: Unveiling the complexities of hypoparathyroidism: a comprehensive review of clinical manifestations, diagnosis, and novel therapies, «JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION», 2025, N/A, pp. N/A - N/A [Review]
Malagrinò, M.; Zavatta, G., Review of: Uric Acid in Primary Hyperparathyroidism: Marker, Consequence, or Bystander?, «METABOLITES», 2025, 15, pp. 1 - 17 [Review]
